TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive In Brief: Fleming New ACCC President, Jennifer Guy President Elect; Rauscher Joins UNIMED Board April 7, 1989
TCL Archive Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific August 12, 2011
TCL Archive Cooperative Groups Not Included Among Grants to Be Funded At Recommended Levels November 11, 1983
TCL Archive It’s Official: House Appropriations Committee Gives NCI $81 Million Increase OverPresident’s Request September 23, 1983